The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis

Human Immunology

Volumn 76, Issue 1, 2015, Pages 22-29

  Zhou, Yan ^a,b   Hou, Weikun ^c   Xu, Ke ^c   Han, Dan ^a   Jiang, Congshan ^a,b   Mou, Kuanhou ^a   Li, Yue ^a,b   Meng, Liesu ^a,b   Lu, Shemin ^a,b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c XI'AN HONGHUI HOSPITAL   (China)

Author keywords

Skin lesion; Systemic sclerosis; Th17

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR 1; INTERLEUKIN 26; INTERLEUKIN 4; INTERLEUKIN RECEPTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN A; ICAM1 PROTEIN, HUMAN; IL17A PROTEIN, HUMAN; IL17RA PROTEIN, HUMAN; IL21R PROTEIN, HUMAN; IL26 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; INTERLEUKIN 21 RECEPTOR ALPHA; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; INTERLEUKIN-22 RECEPTOR; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIUM CELL; EPIDERMIS CELL; EXTRAVASATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN CELL; SKIN DEFECT; SYSTEMIC SCLEROSIS; TH17 CELL; WESTERN BLOTTING; AGED; EARLY DIAGNOSIS; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN;

ADULT; AGED; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-17; INTERLEUKIN-21 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; INTERLEUKINS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-17; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84920831578     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.12.008     Document Type: Article

References (22)

1. O'Reilly S., Hugle T., van Laar J.M. T cells in systemic sclerosis: a reappraisal. Rheumatology (Oxford) 2012, 51:1540-1549.
2. Radstake T.R., van Bon L., Broen J., Hussiani A., Hesselstrand R., Wuttge D.M., et al. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One 2009, 4:e5903.
3. Murata M., Fujimoto M., Matsushita T., Hamaguchi Y., Hasegawa M., Takehara K., et al. Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?. J Dermatol Sci 2008, 50:240-242.
4. Mathian A., Parizot C., Dorgham K., Trad S., Arnaud L., Larsen M., et al. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions. Ann Rheum Dis 2012, 71:1227-1234.
5. Kurebayashi Y., Nagai S., Ikejiri A., Koyasu S. Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells. Genes Cells 2013, 18:247-265.
6. Chen Z., O'Shea J.J. Th17 cells: a new fate for differentiating helper T cells. Immunol Res 2008, 41:87-102.
7. Wright J.F., Bennett F., Li B., Brooks J., Luxenberg D.P., Whitters M.J., et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol 2008, 181:2799-2805.
8. Parrish-Novak J., Foster D.C., Holly R.D., Clegg C.H. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J Leukoc Biol 2002, 72:856-863.
9. Jones B.C., Logsdon N.J., Walter M.R. Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure 2008, 16:1333-1344.
10. Bhattacharyya S., Wei J., Tourtellotte W.G., Hinchcliff M., Gottardi C.G., Varga J. Fibrosis in systemic sclerosis: common and unique pathobiology. Fibrogenesis Tissue Repair 2012, 5(Suppl. 1):S18.
11. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.
12. Clements P., Lachenbruch P., Siebold J., White B., Weiner S., Martin R., et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995, 22:1281-1285.
13. Hachulla E., Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 2011, 40:78-83.
14. Yoshizaki A., Yanaba K., Iwata Y., Komura K., Ogawa A., Akiyama Y., et al. Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol 2010, 185:2502-2515.
15. Kurasawa K., Hirose K., Sano H., Endo H., Shinkai H., Nawata Y., et al. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 2000, 43:2455-2463.
16. Frohlich A., Marsland B.J., Sonderegger I., Kurrer M., Hodge M.R., Harris N.L., et al. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 2007, 109:2023-2031.
17. Pattanaik D., Brown M., Postlethwaite A.E. Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res 2011, 4:105-125.
18. Maurer B., Distler A., Suliman Y.A., Gay R.E., Michel B.A., Gay S., et al. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis. Ann Rheum Dis 2013.
19. Wu P.W., Li J., Kodangattil S.R., Luxenberg D.P., Bennett F., Martino M., et al. IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22. J Mol Biol 2008, 382:1168-1183.
20. Liang M., Wang J., Chu H., Zhu X., He H., Liu Q., et al. Interleukin-22 inhibits bleomycin-induced pulmonary fibrosis. Mediators Inflamm 2013, 2013:209179.
21. Werner S., Smola H. Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol 2001, 11:143-146.
22. Angel P., Szabowski A. Function of AP-1 target genes in mesenchymal-epithelial cross-talk in skin. Biochem Pharmacol 2002, 64:949-956.